PCLAF and allergic rhinitis: The in vivo studies using the only commercially available antihistamines with known anti-PAF activity, such as rupatadine [38], azelastine [46], ketotifen [47] or epinastine [48], have demonstrated their efficacy and safety as a daily treatment for allergic rhinitis.